RPL14 and nasopharyngeal carcinoma: In an in vivo mouse model with subcutaneous injection of RPL14-expressing NPC cells, RPL14 significantly inhibited tumor growth, as evidenced by reduced tumor volume and weight (Figure 7, E–G).